Blog
QbD Model for Clinical Trials Could Cut Costs
The FDA is working on developing a quality-by-design (QbD) model for clinical trials that would cut monitoring costs. The plan is to implement the model within the next 25 years. There is already a QbD model is place for manufacturing that allows for the quality...
Gretchen Miller Bowker, Pearl’s COO, honored by RAPS on October 24, 2011
Gretchen Miller Bowker, Pearl's COO was awarded a very special award today: the RAPS (Regulatory Affairs Professionals Society) Fellow award. As thousands of regulatory compliance professionals converge in Indianapolis, Pearl Pathways’ COO was honored. Visit our...
Mistrust Leads to Decrease in Volunteer Participation
Recently at a conference held by the Institute of Medicine (IOM), low participation in new clinical trials and research were discussed between industry professionals. One viewpoint states mistrust of clinical trials, science in general and the motives of the industry...
National Center for Advancing Translational Science Launch Delayed
The National Center for Advancing Translational Sciences is a research center focused on expediting the process from breakthroughs in the lab to the clinic. Opening of the center has been delayed by funding from the government, with no clear decision in site. The...
Social Media as a Tool for Study Recruitment
At a recent industry conference, a group of panelists at Patient Recruitment Outsourcing (PRO) said the early users of social media are using it productively in patient recruitment, but the industry as a whole is still fearful. The recent changes in technology, and...